Page 750 - Read Online
P. 750

Palacios Mini-invasive Surg 2020;4:73  I  http://dx.doi.org/10.20517/2574-1225.2020.72                                           Page 19 of 24

               PMV NYHA class IV (P = 0.046) as independent predictors of combined events at follow-up. The presence
               of atrial fibrillation per se should not be the only determinant in the decision process regarding treatment
               options in patients with rheumatic mitral stenosis. The presence of an Echo-Sc less than or equal to 8
               primarily identifies a subgroup of patients in atrial fibrillation in whom percutaneous balloon valvotomy
               is likely to be successful and provide good long-term results. Therefore, in this group of atrial fibrillation
                                                                                                [54]
               patients, PMV should be the procedure of choice for the treatment of rheumatic mitral stenosis .

               PMV IN PATIENTS WITH AORTIC REGURGITATION
                                   [56]
               Sanchez-Ledesma et al.  examine the effect of concomitant aortic regurgitation (AR) on PMV procedural
               success, short-term, and long-term clinical outcome in 676 procedures performed. Of which, 361 (53.4%)
               had no AR, 287 (42.5%) mild AR, and 28 (4.1%) moderate AR. There were no differences between groups
               in the pre-procedure characteristics, procedural success, or in the incidence of in-hospital adverse events.
               At a median follow-up of 4.11 years, there was no difference in the overall survival rate (P = 0.22), MVR
               rate (P = 0.69), or redo PMV incidence (P = 0.33). The rate of AVR was higher in the moderate AR group
               (0.9% vs. 1.9% vs. 13%, P = 0.003). Mean time to AVR was 4.5 years and did not differ significantly between
               patients with no AR, mild AR, or moderate AR (2.9 ± 2.1 vs. 5.7 ± vs. 4.1 ± 2.5 years, P = 0.46). They
               concluded that concomitant AR at the time of PMV does not influence procedural success and is not
               associated with inferior outcome. A minority of patients with MS and moderate AR who undergo PMV will
               require subsequent AVR on long-term follow-up. Thus, patients with rheumatic MS and mild to moderate
                                               [56]
               AR remain good candidates for PMV .

               THE DOUBLE-BALLOON VS. THE INOUE TECHNIQUES OF PMV
               Today the Inoue approach of PMV is the technique more widely used. There was controversy as to
               whether the double-balloon or the Inoue technique provided superior immediate and long-term results.
               We compared the immediate procedural and the long-term clinical outcomes after PMV using the
               double-balloon technique (n = 659) and Inoue technique (n = 233). There were no statistically significant
               differences in baseline clinical and morphologic characteristics between the double-balloon technique and
               Inoue technique patients. Although the post-PMV MVA was larger with the double-balloon technique (1.94
               ± 0.72 vs. 1.81 ± 0.58; P < 0.01), success rate (71.3% vs. 69.1%; P = not significant), incidence of greater than
               grade 3 + MR (9% vs. 9%), and in-hospital complications were similar. Furthermore, as shown in Figure 16
               long-term and event-free survival were similar with both techniques [57,58] . In conclusion, both the Inoue and
               the double-balloon techniques are equally effective techniques of PMV. The procedure of choice should be
               performed based on the interventionist experience with the technique [57,58] .

               FOLLOW-UP OF THE BEST PATIENTS
               In patients identified as optimal candidates for PMV, this technique results in excellent immediate and
               long-term outcome. Optimal candidates for PMV are those patients meeting the following characteristics:
               (1) age 45 years old or younger; (2) normal sinus rhythm; (3) Echo-Sc ≤ 8; (4) no history of previous
               surgical commissurotomy; and (5) pre- PMV MR ≤ 1 + Sellers grade [10,50] . From 879 consecutive patients
               undergoing PMV at the Massachusetts General Hospital, the authors identified 136 patients with optimal
                                        [10]
               pre-procedure characteristics . In these patients, PMV results in an 81% success rate and a 3.4% incidence
               of major in-hospital combined events (death and/or MVR). In these patients, PMV results in a 95% survival
               and 61% event-free survival at the 12-year follow-up [10,29,55] .


               PMV IN PATIENTS WITH PULMONARY ARTERY HYPERTENSION
               Patients with mitral stenosis with severe pulmonary hypertension constitute a high-risk subset for surgical
               commissurotomy or valve replacement. The degree of pulmonary artery hypertension before PMV is
               inversely related to the immediate and long-term outcome of PMV . Chen and colleagues divided 564
                                                                          [59]
   745   746   747   748   749   750   751   752   753   754   755